Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Ó Hálfdánarson, JM Cohen, Ø Karlstad… - BMJ Ment …, 2022 - mentalhealth.bmj.com
Background Antipsychotics are increasingly used among women of childbearing age and
during pregnancy. Objective To determine whether children exposed to antipsychotics in …

Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

O Halfdanarson, JM Cohen, Ø Karlstad, CE Cesta… - 2021 - bora.uib.no
Background Antipsychotics are increasingly used among women of childbearing age and
during pregnancy. Objective To determine whether children exposed to antipsychotics in …

[PDF][PDF] Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Ó Hálfdánarson, JM Cohen, Ø Karlstad… - BMJ Ment …, 2021 - mentalhealth.bmj.com
Background Antipsychotics are increasingly used among women of childbearing age and
during pregnancy. Objective To determine whether children exposed to antipsychotics in …

[HTML][HTML] Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Ó Hálfdánarson, JM Cohen, Ø Karlstad… - … -Based Mental Health, 2022 - ncbi.nlm.nih.gov
Objective To determine whether children exposed to antipsychotics in utero are at increased
risk of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) …

[引用][C] Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

O Halfdanarson, JM Cohen, O Karlstad, CE Cesta… - 2021 - julkari.fi
Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism
spectrum disorder : a Nordic cohort study Hyppää sisältöön Näytä/piilota sivun navigointi …

Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Ó Hálfdánarson, JM Cohen… - Evidence-based …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Antipsychotics are increasingly used among women of childbearing age and
during pregnancy. Objective To determine whether children exposed to antipsychotics in …

Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

O Halfdanarson, JM Cohen, Ø Karlstad, CE Cesta… - 2021 - fhi.brage.unit.no
Background Antipsychotics are increasingly used among women of childbearing age and
during pregnancy. Objective To determine whether children exposed to antipsychotics in …

Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Ó Hálfdánarson, JM Cohen, Ø Karlstad, CE Cesta… - 2022 - opinvisindi.is
BACKGROUND: Antipsychotics are increasingly used among women of childbearing age
and during pregnancy. OBJECTIVE: To determine whether children exposed to …

Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Ó Hálfdánarson, JM Cohen, Ø Karlstad… - Evidence-Based …, 2022 - search.proquest.com
Objective To determine whether children exposed to antipsychotics in utero are at increased
risk of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) …

Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study

Ó Hálfdánarson, JM Cohen, Ø Karlstad… - Evidence-Based Mental …, 2022 - pure.au.dk
OBJECTIVE: To determine whether children exposed to antipsychotics in utero are at
increased risk of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder …